Login to Your Account

In The Clinic NEWS
AAN 2015
WASHINGTON – The FDA has been under the gun to qualify more biomarkers that could help accelerate the development of targeted therapies and track the progression of various diseases.
DUBLIN – Has the era of truly personalized cancer immunotherapy begun? Biontech AG certainly thinks so – and the German biotech firm has published in vivo proof-of-concept data in the April 23, 2015, issue of Nature to back up its claims.
AAN 2015
The ginormous 67th American Academy of Neurology (AAN) annual meeting is in full swing, with more than 2,500 abstracts scheduled for presentation at scientific sessions during the week.
More In The Clinic Headlines

Cast Your Vote

Has biotech’s bubble burst?: